Skip to main content

Williamson Robert F III's Form 4 filing

Perspective Therapeutics, Inc.CATX · filed Dec 26, 2023

Accession no.
0001437749-23-035321
Filed
Dec 26, 2023, 5:00 PM ET
Trade date
Dec 21, 2023
Filing delay
5 days
Rule 10b5-1 plan
Not checked

This filing lists 1 non-derivative transaction. Open-market purchases total $1.20K. It was filed 5 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Williamson Robert F IIICIK 0001397331Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Dec 21, 2023Common StockPPurchaseAcquired+3,663$0.3283F1+$1,202.563,663Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

This price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.3249 to $0.3300, inclusive. The reporting person undertakes to provide to Perspective Therapeutics, Inc., any security holder of Perspective Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)